Colchicine and indomethacin for the treatment of relapsing polychondritis.
This report describes the effectiveness of oral colchicine and indomethacin in the maintenance phase of treatment of relapsing polychondritis. Systemic corticosteroids are commonly used in the induction phase of managing cases of relapsing polychondritis. Clinicians are then faced with the challenge of controlling the patient's symptoms while trying to decrease the dose of steroid.
Mark
Kenneth A
KA
Connective Tissue Section of the Charles C. Harris Skin and Cancer Pavilion, The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.
Franks
Andrew G
AG
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D003078:Colchicine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011081:Polychondritis, Relapsing / Q000188:drug therapy* / Q000276:immunology; D011239:Prednisolone / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006074:Gout Suppressants; D011239:Prednisolone; D003078:Colchicine; D007213:Indomethacin